• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply

Welcome to the international HTA database

CSV RIS
Showing [21846 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2006     Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of music therapy in clinical practice
2008     Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of multislice computed tomography for the assessment of liver metastases
2005     Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of multislice computed tomography (MSCT) for coronary disease
2007     Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of multislice computed tomography (MSCT) for coronary disease
2007     Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of intervertebral disc prostheses for spine diseases
2006     Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of hydroxyethyl starch (HES) as plasma expander
2006     Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of hippotherapy
2005     Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of hip arthroscopy
2008     Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of high-intensity focused ultrasound in prostate cancer
2004     Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of extracorporeal shock waves in musculoskeletal disorders
2005     Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of ceramic prosthesis in total hip replacement
2006     Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of ceramic or metal on metal prostheses in total hip replacement
2004     Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of bevacizumab in colon cancer patients
2004     Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of autologous growth factors in orthopaedic surgery
2006     Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of alpha-glucosidase in pompe disease
2006     Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of alpha-glucosidase in Pompe disease
2000     Canadian Task Force on Preventive Health Care (CTFPHC) Use of varicella vaccine in healthy populations: systematic review and recommendations
2004     Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS) Use of ultrasound in antenatal and primary care
2001     Norwegian Knowledge Centre for the Health Services (NOKC) Use of ultrasonography in the primary health care setting
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Use of topical anesthetics for suturing and circumcisions in pediatric patients: a review of clinical effectiveness and guidelines
2011     Technology Assessment Unit of the McGill University Health Centre (MUHC) Use of the VerifyNow point of care test to detect nonresponsiveness to clopidogrel and aspirin
2003     Technology Assessment Unit of the McGill University Health Centre (MUHC) Use of the implantable cardiac defibrillator (ICD) at the McGill University Health Centre (MUHC)
2004     Andalusian Health Technology Assessment Area (AETSA) Use of the drug eluting stents - review
2023     Agency for Healthcare Research and Quality (AHRQ) Use of telehealth during the COVID-19 era
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Use of surgical masks in the operating room: a review of the clinical effectiveness and guidelines
2003     Quality Improvement Scotland (NHS QIS ) Use of stents to treat peripheral arterial disease (PAD)
2005     Agency for Healthcare Research and Quality (AHRQ) Use of spirometry for case finding, diagnosis, and management of chronic obstructive pulmonary disease (COPD)
2007     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Use of sorafenib (Nexavar®) for advanced renal cell carcinoma within NHS Wales
2007     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Use of sodium phenylbutyrate within NHS Wales
2012     Technology Assessment Unit of the McGill University Health Centre (MUHC) Use of serum procalcitonin levels in treatment decisions for adult patients in the intensive care unit
2024     NIHR Health Technology Assessment programme Use of selective gut decontamination in critically ill children: PICnIC a pilot RCT and mixed-methods study
2021     Health Information and Quality Authority (HIQA) Use of respirator masks by persons who are at higher risk from COVID-19
2000     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) Use of resources for oncologic patients during last month of life: the role of PADES (home care and support teams programme)
2007     Andalusian Health Technology Assessment Area (AETSA) Use of recombinant human erythropoietin in orthopedic surgery
2006     Finnish Office for Health Care Technology Assessment (Finohta) Use of quality-adjusted life years for the estimation of effectiveness of health care: a systematic literature review
2001     Agency for Healthcare Research and Quality (AHRQ) Use of positron emission tomography and other neuroimaging techniques in the diagnosis and management of Alzheimer's disease and dementia
2013     HAYES, Inc. Use of positive-displacement needleless connectors and rates of catheter-related bloodstream infections
1999     Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS) Use of polymerase chain reaction
2009     Belgian Health Care Knowledge Centre (KCE) Use of point-of-care devices in patients with oral anticoagulation : a Health Technology Assessment
2009     Belgian Health Care Knowledge Centre (KCE) Use of point-of care devices in patients with oral anticoagulation: a health technology assessment
2016     Belgian Health Care Knowledge Centre (KCE) Use of pneumococcal vaccines in the elderly an economic evaluation
2005     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Use of Pegvisomant (Somavert®) within NHS Wales
2003     Norwegian Knowledge Centre for the Health Services (NOKC) Use of palliative surgery in the treatment of cancer patients
2010     Penn Medicine Center for Evidence-based Practice (CEP) Use of opioids for treatment of fibromyalgia
2010     Penn Medicine Center for Evidence-based Practice (CEP) Use of opioids for treating chronic back pain
2013     HTA Unit, University of Calgary Use of Oncotype DX for guiding adjuvant chemotherapy decisions in early stage invasive breast cancer patients in Alberta
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Use of new versus refurbished surgical tables: comparative clinical effectiveness and guidelines
2013     HAYES, Inc. Use of neutral-displacement needleless connectors and rates of catheter-related bloodstream infections
2013     HAYES, Inc. Use of negative-displacement needleless connectors and rates of catheter-related bloodstream infections
2013     Agency for Healthcare Research and Quality (AHRQ) Use of natriuretic peptide measurement in the management of heart failure
2006     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Use of mycophenolic acid as a sodium salt (Myfortic®) within NHS Wales
2013     Penn Medicine Center for Evidence-based Practice (CEP) Use of midodrine with vasopressors in the intensive care unit
2009     Technology Assessment Unit of the McGill University Health Centre (MUHC) Use of matrix coils in the treatment of cerebro-vascular aneurysms: an update
2001     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Use of mammography and Papanicolaou's test for the early detection of breast and uterine cervix cancer in Spain. IPE-02/34 (Public report)
2006     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Use of liposomal cytarabine (DepoCyte®) within NHS Wales
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Use of lidocaine on adults with open wounds: a review of the safety
2003     Blue Cross Blue Shield Association (BCBS) Use of intermittent or continuous interstitial fluid glucose monitoring in patients with diabetes mellitus
2002     Blue Cross Blue Shield Association (BCBS) Use of intermittent or continuous interstitial fluid glucose monitoring in patients with diabetes mellitus
1999     Alberta Heritage Foundation for Medical Research (AHFMR) Use of In-111 Capromab Pendetide in detecting metastatic prostate cancer
2005     Blue Cross Blue Shield Association (BCBS) Use of implantable cardioverter-defibrillators for prevention of sudden death in patients at high risk for ventricular arrhythmia
2002     Blue Cross Blue Shield Association (BCBS) Use of implantable cardioverter-defibrillators for prevention of sudden death in patients at high risk for ventricular arrhythmia
2007     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Use of iloprost trometamol (Ventavis®) within NHS Wales
2003     Norwegian Knowledge Centre for the Health Services (NOKC) Use of hematopoietic stem cells from cord blood
2003     Agency for Healthcare Research and Quality (AHRQ) Use of glycated hemoglobin and microalbuminuria in the monitoring of diabetes mellitus
2007     Blue Cross Blue Shield Association (BCBS) Use of GeneSearch breast lymph node assay to detect sentinel node metastases in early stage breast cancer
2014     NIHR Health Technology Assessment programme Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review, statistical modelling and survey
2005     Andalusian Health Technology Assessment Area (AETSA) Use of flash sterilization
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Use of fentanyl and continuous electronic fetal monitoring in labour and delivery: a review of clinical effectiveness, safety, and clinical practice guidelines
2006     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Use of FDG-PET in clinical situations not addressed in the monitorized use of this technology. IPE-06/49
2017     Technology Assessment Unit of the McGill University Health Centre (MUHC) Use of extracorporeal membrane oxygenation for cardiac life support in adult subjects
2001     Agency for Healthcare Research and Quality (AHRQ) Use of epoetin for anemia in chronic renal failure
2002     Blue Cross Blue Shield Association (BCBS) Use of epithelial cell cytology in breast cancer risk assessment and high-risk patient management
2015     NIHR Health Technology Assessment programme Use of drug therapy in the management of symptomatic ureteric stones in hospitalised adults: a multicentre, placebo-controlled, randomised controlled trial and cost-effectiveness analysis of a calcium channel blocker (nifedipine) and an alpha-blocker (tamsulosin) (the SUSPEND trial)
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Use of diuretics for hypertension in patients with reduced renal function: a review of clinical effectiveness, safety, and guidelines
2014     Blue Cross Blue Shield Association (BCBS) Use of digital breast tomosynthesis with mammography for breast cancer screening or diagnosis
2024     Belgian Health Care Knowledge Centre (KCE) Use of diagnostic immunohistochemistry and electron microscopy tests in Belgium (Study 2021-01)
2010     Medical Advisory Secretariat (MAS) Use of contrast agents with echocardiography in patients with suboptimal echocardiography
2009     NIHR Health Technology Assessment programme Use of classical and novel biomarkers as prognostic risk factors for prostate cancer: a systematic review
2009     NIHR Health Technology Assessment programme Use of classical and novel biomarkers as prognostic risk factors for localised prostate cancer: a systematic review
2008     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) Use of class 3b and class 4 lasers and intense pulsed light sources for cosmetic procedures in non-medical settings
2000     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Use of cisapride in patients with non-ulcer dyspepsia: a meta-analysis of randomized trials
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Use of chlorhexidine gluconate with alcohol for the prevention of peripheral intravenous device infections: a review of clinical and cost effectiveness, and guidelines
2006     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Use of cetuximab (Erbitux®) within NHS Wales
1998     Comite d'Evaluation et de Diffusion des Innovations Technologiques (CEDIT) Use of CDET gamma-cameras for conventional scintigraphy (systematic review, primary research, expert panel)
2004     Technology Assessment Unit of the McGill University Health Centre (MUHC) Use of carmustine implants (GLIADEL wafer) in patients with malignant glioma at The McGill University Health Centre
2015     Agency for Healthcare Research and Quality (AHRQ) Use of cardiac resynchronization therapy in the Medicare population
2004     Alberta Heritage Foundation for Medical Research (AHFMR) Use of cannabis or cannabinoids for non-malignant chronic pain
1995     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) Use of calcitonin in idiopathic osteoporosis
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Use of bupropion in patients with depression and the associated risk of seizures: safety
2003     Institute for Clinical Effectiveness and Health Policy (IECS) Use of botulinum toxine in the clinical practice
2001     Health Technology Advisory Committee (HTAC) Use of botulinum toxin-A in pain associated with neuromuscular disorders
2007     Agency for Health Technology Assessment in Poland (AHTAPol) Use of bosentan, epoprostenol, iloprost, sildenafil and treprostinil in treatment of pulmonary arterial hypertension in Poland. Budget impact analysis.
2005     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Use of Bortezomib (Velcade®) within NHS Wales
2016     Technology Assessment Unit of the McGill University Health Centre (MUHC) Use of biventricular pacing in atrioventricular heart block
2009     Agency for Healthcare Research and Quality (AHRQ) Use of Bayesian techniques in randomized clinical trials: a CMS case study
2021     Ontario Health Use of B-Type Natriuretic Peptide (BNP) and N-Terminal proBNP (NT-proBNP) as Diagnostic Tests in Adults With Suspected Heart Failure
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Use of azathioprine in adults: safety
2005     Medical Advisory Secretariat (MAS) Use of automated external defibrillators in cardiac arrest: an evidence-based analysis
2005     Medical Advisory Secretariat (MAS) Use of automated external defibrillators in cardiac arrest - health technology literature review
2007     Agency for Healthcare Research and Quality (AHRQ) Use of aspirin and NSAIDs to prevent colorectal cancer; an evidence synthesis